|
Re: RVX FILES ANNUAL INFO FORM
|
5
|
Resverlogix Corp.
|
Jul 28, 2015 10:49AM
|
|
Re: RVX FILES ANNUAL INFO FORM
|
1
|
Resverlogix Corp.
|
Jul 28, 2015 01:43PM
|
|
Re: RVX FILES ANNUAL INFO FORM
|
3
|
Resverlogix Corp.
|
Jul 27, 2015 09:34PM
|
|
Re: RVX FILES ANNUAL INFO FORM
|
7
|
Resverlogix Corp.
|
Jul 27, 2015 11:24PM
|
|
Re: RVX exposure
|
4
|
Resverlogix Corp.
|
Feb 13, 2016 07:03AM
|
|
Re: RVX Current Status
|
6
|
Resverlogix Corp.
|
Feb 27, 2020 09:00AM
|
|
Re: RVX continuous good news
|
8
|
Resverlogix Corp.
|
Jun 01, 2015 10:55PM
|
|
Re: RVX continuous good news
|
2
|
Resverlogix Corp.
|
Jun 04, 2015 03:21PM
|
|
Re: RVX continuous good news
|
6
|
Resverlogix Corp.
|
Jun 02, 2015 10:00AM
|
|
Re: RVX chasing BTI
|
|
Resverlogix Corp.
|
Sep 23, 2016 04:52PM
|
|
Re: RVX chasing BTI
|
|
Resverlogix Corp.
|
Sep 21, 2016 01:43PM
|
|
Re: RVX buyout projection at $30 US minimum
|
4
|
Resverlogix Corp.
|
Nov 01, 2018 05:33PM
|
|
Re: RVX announces...THIS IS FROM RVX
|
2
|
Resverlogix Corp.
|
Oct 13, 2017 10:42AM
|
|
Re: RVX ANNOUNCES TYPE C MEETING WITH FDA FOR CORAL, A PHASE 3 HIGH-RISK COVID-19 OUTPATIENT STUDY
|
9
|
Resverlogix Corp.
|
May 10, 2022 12:26PM
|
|
Re: RVX ANNOUNCES LEAD DRUG APABETALONE PUBLICATION AND BIO 2016 PRESENTATION
|
6
|
Resverlogix Corp.
|
Jun 02, 2016 03:11PM
|
|
Re: RVX ANNOUNCES DOSING OF FIRST TWO PATIENTS IN EXPANDED RENAL AND ORPHAN PROGRAMS
|
3
|
Resverlogix Corp.
|
Jul 21, 2016 02:42PM
|
|
Re: RVX Announces 2nd Positive Recommendation From DSMB
|
3
|
Resverlogix Corp.
|
Dec 05, 2016 01:18PM
|
|
Re: RVX Announces 2nd Positive Recommendation From DSMB
|
|
Resverlogix Corp.
|
Dec 05, 2016 01:42PM
|
|
Re: RVX Announces 2nd Positive Recommendation From DSMB
|
4
|
Resverlogix Corp.
|
Dec 05, 2016 01:48PM
|
|
Re: RVX Announces 2nd Positive Recommendation From DSMB
|
2
|
Resverlogix Corp.
|
Dec 05, 2016 04:13PM
|
